Picture Berlin Partner BIO 2024 International Convention San Diego 650x100px

Organisation › Details

AiCuris GmbH & Co. KG

https://www.aicuris.com

	Start	2006-03-22 splitoff
	Group	STRÜNGMANN Group (family Strüngmann)
	Predecessor	Bayer HealthCare AG
	Industry	anti-infective drug
	Person	Rübsamen-Schaeff, Helga (AiCuris 200603– before Bayer HealthCare anti-infectives research)
	Person 2	Schmoll, Holger (AiCuris –2010–202212 CFO LEFT 12/22)

	Region	Wuppertal
	Country	Germany
	Street	475 Friedrich-Ebert-Str. Building 302
	City	42117 Wuppertal
	Tel	+49-202-31763-0
		Address record changed: 2020-12-02

Basic data	Employees	C: 51 to 100 (2012-10-06)


		Record changed: 2023-12-30

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x200px

More documents for STRÜNGMANN Group (family Strüngmann)

[1] AiCuris Anti-infective Cures AG. (8/23/23). "Press Release: AiCuris Received 30 Million Euros Milestone Payment from Licensing Partner MSD Following U.S. FDA Approval of Prevymis (letermovir) in Second Indication". Wuppertal....
[2] AiCuris Anti-infective Cures AG. (7/6/23). "Press Release: AiCuris Announces Strategic Shift to Focus Development and Commercialization of Anti-infectives for Immunocompromised Patients". Wuppertal....
[3] AMSilk GmbH. (4/4/23). "Press Release: AMSilk Announces Extension of Series C Financing to EUR 54M". Munich....
[4] AiCuris Anti-infective Cures AG. (4/4/23). "Press Release: AiCuris AG Announces Appointment of Larry Edwards as Chief Executive Officer and Formation of U.S. Subsidiary". Cambridge....
[5] AiCuris Anti-infective Cures AG. (9/1/22). "Press Release: AiCuris Appoints Experienced Business Leader Dr. Sabrina Kuttruff-Coqui as Chief Financial Officer". Wuppertal....
[6] AiCuris Anti-infective Cures AG. (2/9/22). "Press Release: AiCuris and Hybridize Therapeutics Enter Worldwide License Agreement of up to €100M for a Direct-acting RNA-based Therapy against BK Virus". Wuppertal & Leiden....
[7] AiCuris Anti-infective Cures AG. (7/8/21). "Press Release: AiCuris Starts Its First Pivotal Clinical Phase 3 Trial with Pritelivir for the Treatment of Herpes Simplex Virus Infections in Immunocompromised Subjects". Wuppertal....
[8] AiCuris Anti-infective Cures AG. (5/25/21). "Press Release: AiCuris AG Announces Dr. Stefan Oschmann, Former Merck CEO, to Chair the AiCuris Supervisory Board". Wuppertal....
[9] AiCuris Anti-infective Cures GmbH. (6/9/20). "Press Release: Royalty Pharma Acquires Partial Royalty Interest on Prevymis (Letermovir) from AiCuris Anti-infective Cures GmbH". New York, NY & Wuppertal....
[10] 4SC AG. (11/12/19). "Press Release: 4SC AG Secures circa EUR 22.4 Million from a Capital Increase [Not for release in US, Australia, Canada, et al.]". Planegg-Martinsried....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)